Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Subgroup Analysis of Plant-Based Dietary Patterns and Risks of Incident Type 2 Diabetes, Cardiovascular Disease, Cancer, and Mortality

From: Associations between plant-based dietary patterns and risks of type 2 diabetes, cardiovascular disease, cancer, and mortality – a systematic review and meta-analysis

Characteristics

Study estimates, No.

Relative Risk (95% CI)

  

Inverse-Variance

Fixed-Effects Meta-analysis

Random-Effects

Meta-analysis

I2, %

P value for Heterogeneity Between Subgroups

Type 2 diabetes

     

 Main estimate

22

0.84 (0.81–0.86)

0.81 (0.77–0.86)

59.7

 

 Age, y

    

0.56

  <55

11

0.81 (0.78–0.85)

0.79 (0.73–0.87)

68.7

 

  ≥55

11

0.85 (0.82–0.89)

0.84 (0.79–0.89)

42.0

 

 Sex

    

0.48

  Studies among males only

2

0.81 (0.72–0.90)

0.79 (0.63–0.99)

75.4

 

  Studies among females only

6

0.86 (0.82–0.89)

0.85 (0.79–0.91)

64.8

 

  Studies among males and females

14

0.82 (0.78–0.86)

0.81 (0.77–0.86)

58.3

 

 BMI, kg/m2

    

0.90

  <25

11

0.83 (0.79–0.86)

0.81 (0.75–0.88)

67.8

 

  ≥25

11

0.84 (0.81–0.88)

0.82 (0.76–0.87)

51.8

 

 Region

    

0.87

  North America

12

0.85 (0.82–0.89)

0.82 (0.76–0.88)

60.1

 

  Europe

4

0.78 (0.72–0.84)

0.79 (0.71–0.87)

43.5

 

  Asia/Australia

6

0.83 (0.79–0.88)

0.82 (0.73–0.91)

66.4

 

 Dietary pattern classification

    

0.048

  Vegan or vegetarian diets

5

0.75 (0.67–0.84)

0.63 (0.47–0.84)

77.4

 

  A priori-defined PDI

17

0.84 (0.82–0.87)

0.83 (0.80–0.87)

48.3

 

 Follow-up duration, y

    

0.22

  <15

11

0.81 (0.77–0.86)

0.76 (0.68–0.84)

66.3

 

  ≥15

11

0.84 (0.81–0.86)

0.84 (0.79–0.88)

51.5

 

Cardiovascular disease

     

 Main estimate

23

0.90 (0.87–0.92)

0.89 (0.85–0.94)

51.0

 

 Age, y

    

0.88

  <55

16

0.89 (0.85–0.93)

0.87 (0.80–0.96)

63.8

 

  ≥55

7

0.90 (0.87–0.93)

0.89 (0.85–0.93)

0

 

 Sex

    

0.68

  Studies among males only

3

0.94 (0.85–1.04)

0.94 (0.85–1.04)

0

 

  Studies among females only

6

0.90 (0.85–0.94)

0.90 (0.85–0.94)

0

 

  Studies among males and females

14

0.89 (0.86–0.93)

0.86 (0.79–0.97)

68.1

 

 BMI, kg/m2

    

0.76

  <25

7

0.91 (0.85–0.98)

0.87 (0.72–1.05)

77.9

 

  ≥25

12

0.90 (0.87–0.93)

0.90 (0.87–0.93)

0

 

 Region

    

0.02

  North America

14

0.89 (0.86–0.93)

0.89 (0.85–0.94)

16.2

 

  Europe

7

0.91 (0.87–0.95)

0.91 (0.83-1.00)

71.5

 

  Asia/Australia

2

0.52 (0.35–0.76)

0.52 (0.35–0.76)

0

 

 Dietary classification

    

0.99

  Vegan or vegetarian diets

5

0.90 (0.86–0.95)

0.85 (0.70–1.03)

85.0

 

  A priori-defined PDI

18

0.90 (0.87–0.93)

0.90 (0.86–0.93)

6.1

 

 Follow-up duration, y

    

0.45

  <15

8

0.91 (0.87–0.95)

0.86 (0.77–0.96)

46.0

 

  ≥15

15

0.89 (0.86–0.93)

0.90 (0.85–0.96)

55.9

 

Cancer

     

 Main estimate

32

0.90 (0.87–0.92)

0.88 (0.85–0.92)

29.0

 

 Age, y

    

0.86

  <55

14

0.88 (0.85–0.92)

0.88 (0.85–0.92)

0

 

  ≥55

16

0.91 (0.87–0.94)

0.88 (0.82–0.94)

50.2

 

 Sex

    

0.40

  Studies among males only

5

0.89 (0.84–0.95)

0.83 (0.70–0.98)

75.3

 

  Studies among females only

12

0.90 (0.86–0.94)

0.90 (0.86–0.94)

0

 

  Studies among males and females

15

0.89 (0.86–0.93)

0.87 (0.82–0.92)

18.5

 

 BMI, kg/m2

    

0.51

  <25

12

0.90 (0.87–0.94)

0.90 (0.87–0.94)

0

 

  ≥25

19

0.89 (0.86–0.93)

0.87 (0.81–0.92)

41.0

 

 Region

    

0.39

  North America

20

0.89 (0.85–0.92)

0.86 (0.81–0.91)

47.7

 

  Europe

12

0.91 (0.87–0.95)

0.91 (0.86–0.95)

0

 

  Asia/Australia

     

 Dietary classification

    

0.14

  Vegan or vegetarian diets

16

0.85 (0.80–0.91)

0.85 (0.80–0.91)

0

 

  A priori-defined PDI

16

0.91 (0.88–0.93)

0.90 (0.85–0.94)

43.0

 

 Follow-up duration, y

    

0.98

  <15

15

0.90 (0.86–0.94)

0.87 (0.81–0.94)

38.2

 

  ≥15

17

0.89 (0.86–0.93)

0.88 (0.84–0.93)

23.4

 

Mortality

     

 Main estimate

32

0.86 (0.84–0.87)

0.85 (0.79–0.91)

94.6

 

 Age, y

    

0.77

  <55

17

0.87 (0.85–0.88)

0.88 (0.80–0.96)

95.9

 

  ≥55

12

0.88 (0.85–0.90)

0.86 (0.80–0.94)

83.9

 

 Sex

    

0.66

  Studies among males only

3

0.94 (0.91–0.97)

0.92 (0.86–0.99)

66.4

 

  Studies among females only

3

0.85 (0.82–0.88)

0.90 (0.77–1.04)

91.6

 

  Studies among males and females

26

0.83 (0.82–0.85)

0.83 (0.76–0.91)

95.5

 

 BMI, kg/m2

    

0.24

  <25

12

0.89 (0.87–0.91)

0.90 (0.84–0.95)

86.6

 

  ≥25

11

0.83 (0.80–0.86)

0.84 (0.77–0.92)

77.0

 

 Region

    

0.56

  North America

13

0.89 (0.87–0.90)

0.87 (0.81–0.94)

92.6

 

  Europe

14

0.75 (0.73–0.78)

0.80 (0.67–0.96)

96.4

 

  Asia/Australia

5

0.88 (0.84–0.92)

0.86 (0.76–0.97)

80.9

 

 Dietary classification

    

0.90

  Vegan or vegetarian diets

14

0.76 (0.74–0.78)

0.86 (0.73–1.01)

96.4

 

  A priori-defined PDI

18

0.89 (0.87–0.90)

0.85 (0.80–0.91)

90.6

 

 Follow-up duration, y

    

0.16

  <15

20

0.80 (0.78–0.82)

0.81 (0.74–0.89)

91.2

 

  ≥15

12

0.88 (0.87–0.90)

0.90 (0.80-1.00)

97.1

 
Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us